FOLD R&D Expenses

Amicus Therapeutics Inc · R&D Expenses

FOLD logo

FOLD R&D Expenses

Latest reported$135.84M
FOLD FY R&D Expenses ($4.43M → $135.84M)
High-resolution chart · PNG

FOLD r&d expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Amicus Therapeutics Inc R&D Expenses — Annual fiscal periods (USD)
Period endingR&D Expenses (USD)
135,843,000
109,362,000
152,381,000
276,677,000
272,049,000
308,443,000
286,378,000
270,902,000
149,310,000
104,793,000
76,943,000
47,624,000
41,944,000
50,273,000
50,856,000
39,042,000
48,081,000
37,764,000
31,074,000
33,630,262
13,651,640
0
4,433,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.